CDEK
← All trials

NCT03302065

Phase 1Interventional

Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.

View on ClinicalTrials.gov ↗

Timeline

Start date
May 31, 2016
Primary completion
Sep 30, 2016
Completion date
Jan 31, 2017
First posted
—
Last posted
—
Enrollment
38
Arms / groups
4 / —
Source
AACT · ingestion pipeline

Sponsors

  • 3MLead sponsor
  • 3MStudy chair

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.